7 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $568M | $23M | 68.3% | 9.5% | $72M | $294M | $51M |
| 2024 | $573M | -$36M | 67.7% | -2.7% | $38M | $336M | $42M |
| 2023 | $512M | -$156M | 64.1% | -16.0% | $8M | $395M | $37M |
| 2022 | $512M | -$159M | 64.6% | -32.7% | -$15M | $418M | $30M |
| 2021 | $431M | -$7M | 70.3% | 2.8% | $9M | $358M | $44M |
| 2020 | $321M | $16M | 72.7% | 6.6% | $55M | $188M | $87M |
| 2019 | $340M | $7M | 73.3% | 9.2% | $38M | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $132M | $3M | 68.7% | 6.4% | $8M | $272M | $36M |
| Dec '25 | $158M | $15M | 68.9% | 12.3% | $37M | $294M | $51M |
| Sep '25 | $139M | $3M | 68.0% | 8.1% | $30M | $323M | $42M |
| Jun '25 | $148M | $7M | 69.1% | 12.4% | $25M | $341M | $33M |
| Mar '25 | $124M | -$3M | 67.0% | 3.9% | -$20M | $346M | $23M |
| Dec '24 | $154M | -$388000 | 66.8% | 5.0% | $19M | $336M | $42M |
| Sep '24 | $139M | -$5M | 67.3% | 2.6% | $10M | $384M | $43M |
| Jun '24 | $151M | -$26M | 68.5% | -20.8% | $15M | $383M | $32M |
| Mar '24 | $129M | -$5M | 68.3% | 3.8% | -$6M | $391M | $25M |
| Dec '23 | $135M | -$6M | 63.7% | 0.9% | $10M | $395M | $37M |
| Sep '23 | $121M | -$7M | 65.3% | 2.0% | -$10M | $395M | $27M |
| Jul '23 | $137M | -$4M | 65.0% | 4.9% | $9M | $386M | $29M |
| Apr '23 | $119M | -$139M | 62.1% | -77.3% | -$1M | $446M | $47M |
| Dec '22 | $126M | -$32M | 59.0% | -12.4% | $2M | $418M | $30M |
| Oct '22 | $129M | -$108M | 65.7% | -98.6% | -$2M | $424M | $34M |
| Jul '22 | $140M | -$7M | 68.9% | -2.4% | $909000 | $374M | $41M |
| Apr '22 | $117M | -$11M | 64.5% | -18.3% | -$24M | $368M | $27M |
| Dec '21 | $130M | -$364000 | 67.3% | -2.4% | $10M | $358M | $44M |
| Oct '21 | $109M | -$1M | 72.6% | -1.0% | $9M | $177M | $81M |
| Jul '21 | $110M | -$4M | 69.5% | -5.2% | $16M | $181M | $136M |
How the market has priced BVS against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Bioventus Inc.'s revenue has grown 12.1% per year, and net income grown 6.7% per year. These are computed facts, not advice.
As of FY2025, Bioventus Inc. reported $294M of total debt against $51M of cash.
In FY2025, gross margin was 68.3%, operating margin 9.5%, and net margin 4.0%.
As of Jun '26, Bioventus Inc. traded at a price-to-earnings ratio of about 28.8× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.